BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22327716)

  • 1. The effect of intraventricular thrombolysis in combination with low-frequency head motion after severe subarachnoid hemorrhage: interim analysis of safety, clot clearance rate and delayed cerebral ischemia.
    Eicker SO; Beseoglu K; Etminan N; Perrin J; Taskin A; Steiger HJ; Hänggi D
    Acta Neurochir Suppl; 2012; 114():323-8. PubMed ID: 22327716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm.
    Hänggi D; Eicker S; Beseoglu K; Behr J; Turowski B; Steiger HJ
    Cent Eur Neurosurg; 2009 May; 70(2):61-7. PubMed ID: 19711257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of lumboventricular lavage and simultaneous low-frequency head-motion therapy after severe subarachnoid hemorrhage: results of a single center prospective Phase II trial.
    Hänggi D; Liersch J; Turowski B; Yong M; Steiger HJ
    J Neurosurg; 2008 Jun; 108(6):1192-9. PubMed ID: 18518727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method of aneurysm treatment does not affect clot clearance after aneurysmal subarachnoid hemorrhage.
    Ibrahim GM; Vachhrajani S; Ilodigwe D; Kassell NF; Mayer SA; Ruefenacht D; Schmiedek P; Weidauer S; Pasqualin A; Macdonald RL
    Neurosurgery; 2012 Jan; 70(1):102-9; discussion 109. PubMed ID: 21788917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective, randomized, open-label phase II trial on concomitant intraventricular fibrinolysis and low-frequency rotation after severe subarachnoid hemorrhage.
    Etminan N; Beseoglu K; Eicker SO; Turowski B; Steiger HJ; Hänggi D
    Stroke; 2013 Aug; 44(8):2162-8. PubMed ID: 23735957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin decreases computed tomography and S100-assessed brain ischemia after subarachnoid aneurysmal hemorrhage: a comparative study.
    Sanchez-Peña P; Nouet A; Clarençon F; Colonne C; Jean B; Le Jean L; Fonfrede M; Aout M; Vicaut E; Puybasset L
    Crit Care Med; 2012 Feb; 40(2):594-602. PubMed ID: 21926584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early whole-brain CT perfusion for detection of patients at risk for delayed cerebral ischemia after subarachnoid hemorrhage.
    Malinova V; Dolatowski K; Schramm P; Moerer O; Rohde V; Mielke D
    J Neurosurg; 2016 Jul; 125(1):128-36. PubMed ID: 26684786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Subarachnoid hemorrhage, cerebral ischemia and endothelin-1].
    Secades JJ; Rubio E; Castellanos JM; de la Rosa MD; Mercadal J; Vilalta J; Catalán R; Galard RM
    Rev Neurol; 2000 Jan 1-15; 30(1):27-34. PubMed ID: 10742992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
    Hänggi D; Beseoglu K; Turowski B; Steiger HJ
    Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study.
    Westermaier T; Stetter C; Vince GH; Pham M; Tejon JP; Eriskat J; Kunze E; Matthies C; Ernestus RI; Solymosi L; Roosen K
    Crit Care Med; 2010 May; 38(5):1284-90. PubMed ID: 20228677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of delayed cerebral ischemia after subarachnoid hemorrhage.
    Koenig MA
    Continuum (Minneap Minn); 2012 Jun; 18(3):579-97. PubMed ID: 22810250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo.
    Wurm G; Tomancok B; Nussbaumer K; Adelwöhrer C; Holl K
    Clin Neurol Neurosurg; 2004 Mar; 106(2):97-103. PubMed ID: 15003298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial.
    Muroi C; Terzic A; Fortunati M; Yonekawa Y; Keller E
    Surg Neurol; 2008 Jan; 69(1):33-9; discussion 39. PubMed ID: 18054611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrovascular carbon dioxide reactivity and delayed cerebral ischemia after subarachnoid hemorrhage.
    Carrera E; Kurtz P; Badjatia N; Fernandez L; Claassen J; Lee K; Schmidt JM; Connolly ES; Marshall RS; Mayer SA
    Arch Neurol; 2010 Apr; 67(4):434-9. PubMed ID: 20385909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of delayed ischemic neurological deficits after aneurysmal subarachnoid hemorrhage and implications for regional neuromonitoring.
    Miller CM; Palestrant D
    Clin Neurol Neurosurg; 2012 Jul; 114(6):545-9. PubMed ID: 22176917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volumetric quantification of Fisher Grade 3 aneurysmal subarachnoid hemorrhage: a novel method to predict symptomatic vasospasm on admission computerized tomography scans.
    Friedman JA; Goerss SJ; Meyer FB; Piepgras DG; Pichelmann MA; McIver JI; Toussaint LG; McClelland RL; Nichols DA; Atkinson JL; Wijdicks EF
    J Neurosurg; 2002 Aug; 97(2):401-7. PubMed ID: 12186469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral Vasospasm and Delayed Cerebral Ischemia after Warfarin-Induced Subarachnoid Hemorrhage.
    Ricarte IF; Calente FG; Alves MM; Gomes DL; Valiente RA; Carvalho FA; Silva GS
    J Stroke Cerebrovasc Dis; 2015 Sep; 24(9):e275-8. PubMed ID: 26198372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial.
    Vergouwen MD; Meijers JC; Geskus RB; Coert BA; Horn J; Stroes ES; van der Poll T; Vermeulen M; Roos YB
    J Cereb Blood Flow Metab; 2009 Aug; 29(8):1444-53. PubMed ID: 19458605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.